TransCode retains Tungsten Advisors for strategic review of oncology portfolioOct 28PartnershipTransCode Therapeutics
TransCode pays down $840,975 to Yorkville after convertible notes breach floor priceOct 1FinancingTransCode Therapeutics
TransCode reports updated Phase 1a data for TTX-MC138 in advanced solid tumorsSep 28Clinical readoutTransCode Therapeutics